Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05928221 · ClinicalTrials.gov registry record
Post Market Registry Study of the Philips QuickClear Mechanical Thrombectomy System
A clinical trial of Acute Deep Venous Thrombosis of Ileofemoral Vein, sponsored by Paul J. Gagne.
- Active
- Registry status
- 50
- Enrollment target
- 6
- Study locations
NCT05928221 is a study of Acute Deep Venous Thrombosis of Ileofemoral Vein that is active but no longer recruiting, run by Paul J. Gagne. The registered enrollment target is 50 participants. The trial reports 6 study locations across 2 states.
The verdict
NCT05928221, a study of Acute Deep Venous Thrombosis of Ileofemoral Vein, is active but no longer recruiting, sponsored by Paul J. Gagne.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 6
- Study locations
Study Summary
A post-market study of the QuickClear Mechanical Thrombectomy system used for the removal of acute Deep Vein Thrombosis (DVT) from the deep veins of legs in the setting of an office interventional suite.
Conditions Studied
Interventions
- DEVICE Thrombectomy
Study Locations (6)
Massachusetts
- The Vascular Care Group - Hyannis
- The Vascular Care Group - Leominster
- The Vascular Care Group - Plymouth
- The Vascular Care Group - Wellesley
- The Vascular Care Group - Worcester
Connecticut
- Vascular Care Connecticut - Darien
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-06-14 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05928221
The ClinicalTrials.gov registry entry for NCT05928221 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paul J. Gagne, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Deep Venous Thrombosis of Ileofemoral Vein appearing as the primary indexed condition, and to 1 intervention - of which Thrombectomy is the first listed.
NCT05928221 reports 6 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05928221 about?
NCT05928221 is a clinical study titled "Post Market Registry Study of the Philips QuickClear Mechanical Thrombectomy System". A post-market study of the QuickClear Mechanical Thrombectomy system used for the removal of acute Deep Vein Thrombosis (DVT) from the deep veins of legs in the setting of an office interventional suite.
What is the current status of trial NCT05928221?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2023-06-14. Estimated completion is 2026-07.
What conditions does trial NCT05928221 study?
This clinical trial studies the following conditions: Acute Deep Venous Thrombosis of Ileofemoral Vein.
What interventions are being tested in trial NCT05928221?
The interventions under investigation include: Thrombectomy (DEVICE).
Who is sponsoring clinical trial NCT05928221?
This trial is sponsored by Paul J. Gagne, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05928221 being conducted?
This trial has 6 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.